FSDDF - FSD Pharma Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.1350
+0.0260 (+23.85%)
As of 1:27PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.1090
Open0.1260
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1215 - 0.1375
52 Week Range0.0870 - 0.8750
Volume523,345
Avg. Volume310,945
Market Cap190.185M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0010
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Business Wire6 hours ago

    FSD Pharma Receives Full “Sale for Medical Purposes” Cannabis License from Health Canada

    FSD Pharma Inc. (HUGE.CN) (FSDDF) (0K9.F) (“FSD” or the “Company”), announced today that its wholly-owned subsidiary FV Pharma Inc. (“FV Pharma”) has received its Full Sale for Medical Purposes license to sell cannabis under the Cannabis Act (Canada). The latest amendment to the license, originally granted on April 18, 2019, allows the FSD facility in Cobourg, Ontario to supply and sell cannabis products, including dried and fresh cannabis to the medicinal use marketplace.

  • FSD Pharma Receives Full "Sale for Medical Purposes" Cannabis License from Health Canada
    CNW Group6 hours ago

    FSD Pharma Receives Full "Sale for Medical Purposes" Cannabis License from Health Canada

    TORONTO, June 24, 2019 /CNW/ - FSD Pharma Inc. (CSE:HUGE.CN - News) (OTCQB:FSDDF - News) (FRA:0K9.F - News) ("FSD" or the "Company"), announced today that its wholly-owned subsidiary FV Pharma Inc. ("FV Pharma") has received its Full Sale for Medical Purposes license to sell cannabis under the Cannabis Act (Canada). The latest amendment to the license, originally granted on April 18, 2019, allows the FSD facility in Cobourg, Ontario to supply and sell cannabis products, including dried and fresh cannabis to the medicinal use marketplace. FV Pharma can now begin delivering cannabis to patients who hold prescriptions from authorized healthcare providers.

  • Newsfile10 days ago

    FSD Pharma Continues to Add Expert Advisors Amid Buildout of Massive Facility -- CFN Media

    Seattle, Washington--(Newsfile Corp. - June 14, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF). The company has been focused on building out its board of directors and advisory board since becoming a full Canadian licensed producer earlier this year. After receiving its cultivation license in 2017, the company ...

  • CNW Group11 days ago

    High Tide Announces AGCO Authorization to Open Canna Cabana Toronto Retail Cannabis Store

    /NOT FOR DISTRIBUTION TO NEWSWIRE SERVICES IN THE UNITED STATES OR FOR DISSEMINATION IN THE UNITED STATES . ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES ...

  • FSD Pharma Adds Biotech/LifeSciences Industry veteran James A. Datin and Robert J. Ciaruffoli, Former Chairman & CEO of Parente Beard/Baker Tilly to Board of Directors
    CNW Group12 days ago

    FSD Pharma Adds Biotech/LifeSciences Industry veteran James A. Datin and Robert J. Ciaruffoli, Former Chairman & CEO of Parente Beard/Baker Tilly to Board of Directors

    TORONTO, June 12, 2019 /CNW/ - FSD Pharma Inc. (CSE:HUGE.CN - News) (OTCQB:FSDDF - News) (FRA:0K9.F - News) ("FSD" or the "Company"), today announced the appointment of James A. Datin and Robert J. Ciaruffoli, CPA to the Company's Board of Directors. "It is an honor to welcome Jim Datin and Bob Ciaruffoli to the FSD Pharma Board of Directors," said Dr. Raza Bokhari, Executive Co-Chairman and CEO. "The experience and expertise they both bring as c-level entrepreneurial executives, leaders and board members of impressive organizations will add tremendous value to FSD.

  • Business Wire12 days ago

    FSD Pharma Adds Biotech/LifeSciences Industry veteran James A. Datin and Robert J. Ciaruffoli, Former Chairman & CEO of Parente Beard/Baker Tilly to Board of Directors

    FSD Pharma Inc. (HUGE.CN) (FSDDF) (0K9.F) ("FSD" or the "Company"), today announced the appointment of James A. Datin and Robert J. Ciaruffoli, CPA to the Company’s Board of Directors. “It is an honor to welcome Jim Datin and Bob Ciaruffoli to the FSD Pharma Board of Directors,” said Dr. Raza Bokhari, Executive Co-Chairman and CEO. “The experience and expertise they both bring as c-level entrepreneurial executives, leaders and board members of impressive organizations will add tremendous value to FSD.

  • Business Wire18 days ago

    FSD Pharma Adds Two More Prominent Cannabis Researchers to Scientific Advisory Board

    FSD Pharma Inc. (HUGE.CN) (FSDDF) (0K9.F) (“FSD” or the “Company”), is pleased to announce the addition of two distinguished cannabis researchers to the company’s Scientific Advisory Board (“SAB”). “It is with great pride that we welcome Dr. Ziva Cooper and Dr. Mallory Loflin to our Scientific Advisory Board. The board, which also includes Dr. Daniel Piomelli and Dr. Ryan Vandrey, is shaping into a very robust body of scientists and researchers under the leadership of my good friend Dr. Pollack and I commend him for his leadership.

  • FSD Pharma Adds Two More Prominent Cannabis Researchers to Scientific Advisory Board
    CNW Group18 days ago

    FSD Pharma Adds Two More Prominent Cannabis Researchers to Scientific Advisory Board

    TORONTO, June 6, 2019 /CNW/ - FSD Pharma Inc. (CSE:HUGE.CN - News) (OTCQB:FSDDF - News) (FRA:0K9.F - News) ("FSD" or the "Company"), is pleased to announce the addition of two distinguished cannabis researchers to the company's Scientific Advisory Board ("SAB"). "It is with great pride that we welcome Dr. Ziva Cooper and Dr. Mallory Loflin to our Scientific Advisory Board.

  • Newsfile20 days ago

    FSD Pharma Brings in World-Renowned Experts to Build Bioscience Division -- CFN Media

    Seattle, Washington--(Newsfile Corp. - June 4, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF). The company may be known for having one of the largest cultivation footprints in the world with nearly 70 acres and four million square feet, but it's equally focused on advancing the science behind ...

  • CNW Group20 days ago

    High Tide Announces Smoker's Corner Store in the Royal Chapelle Area of Edmonton

    CALGARY, June 4, 2019 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (CSE:HITI.CN - News) (OTCQB:HITIF - News) (FRA:2LY.F - News), an Alberta-based, retail-focused cannabis corporation enhanced by the manufacturing and wholesale distribution of smoking accessories and cannabis lifestyle products, today announced that it has opened a new Smoker's Corner retail store in the Royal Chapelle Area of Edmonton, specifically located at 3142 141 Street SW in Edmonton, Alberta (the "Royal Chapelle Store"). Similar to High Tide's other Smoker's Corner locations, the Royal Chapelle Store will be supplied from the Company's vast catalogue of more than 4,300 SKUs of smoking accessories and cannabis lifestyle products, including the full range of proprietary and licensed goods offered by its wholesale segment.

  • Dr. Raza Bokhari, FSD Pharma Executive Co-Chairman and CEO to Participate in Biotech-Focused Panel at the 2019 BIO International Convention
    CNW Group21 days ago

    Dr. Raza Bokhari, FSD Pharma Executive Co-Chairman and CEO to Participate in Biotech-Focused Panel at the 2019 BIO International Convention

    Panel to Feature Discussion About Creating a Winning Culture in the Biotech Industry TORONTO , June 3, 2019 /CNW/ - FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) ("FSD" or the "Company"), ...

  • Business Wire21 days ago

    FSD Pharma Names Raza Bokhari, M.D. as Permanent CEO

    The Board of Directors of FSD Pharma Inc. (HUGE.CN) (FSDDF) (0K9.F) ("FSD" or the "Company"), unanimously voted Raza Bokhari, M.D., Executive Co-Chairman of the Board, as permanent Chief Executive Officer. Dr. Bokhari has served as interim CEO of the Company since February.

  • FSD Pharma Congratulates High Tide on the Resumption of Retail Cannabis Licensing by AGLC in Alberta
    CNW Group24 days ago

    FSD Pharma Congratulates High Tide on the Resumption of Retail Cannabis Licensing by AGLC in Alberta

    TORONTO, May 31, 2019 /CNW/ - FSD Pharma Inc. (CSE:HUGE.CN - News) (OTCQB:FSDDF - News) (FRA:0K9.F - News) ("FSD" or the "Company") would like to congratulate High Tide Inc. (CSE:HITI) (OTCQB:HITIF - News) (FRA:2LY.F - News) ("High Tide") on the recent announcement from Alberta Gaming, Liquor and Cannabis lifting the moratorium on issuing cannabis licenses and accepting license applications. The announcement is an encouraging sign of steadily improving cannabis supply levels in Alberta and is a positive step for companies like High Tide that have numerous stores ready and waiting to retail cannabis products. As a strategic investor in High Tide, FSD Pharma is pleased to see changes that will support the continued growth and success of the cannabis industry as well as the companies in which it is invested.

  • CNW Group24 days ago

    High Tide Celebrates Lifting of Alberta Retail Licencing Moratorium with 9 More Stores Ready to Sell Cannabis Products

    CALGARY, May 31, 2019 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (CSE:HITI.CN - News) (OTCQB:HITIF - News) (FRA:2LY.F - News), an Alberta-based, retail-focused cannabis corporation enhanced by the manufacturing and wholesale distribution of smoking accessories and cannabis lifestyle products, today is celebrating the announcement by Alberta Gaming, Liquor and Cannabis ("AGLC") that it has lifted the moratorium on issuing retail cannabis licences and accepting new licence applications. The announcement provides certainty and clarity for the licencing of nine approved Canna Cabana locations currently selling accessories, as well as for the next 23 locations in various stages of development, in addition to the four Canna Cabana locations currently selling cannabis in Alberta. AGLC will be issuing five licences per week until all approved locations have been licenced.

  • Auxly Cannabis Group's First-Quarter Loss Widens as It Focuses on Marijuana Derivatives
    Motley Fool25 days ago

    Auxly Cannabis Group's First-Quarter Loss Widens as It Focuses on Marijuana Derivatives

    Auxly recorded its first marijuana sales in Q1, but revenue isn't expected to really pick up until October.

  • CNW Group26 days ago

    Halo Labs Announces Strategic Partnership with High Tide for Exclusive Distribution of DabTabs™ Home Preparation Kits

    /Not for Distribution to U.S. Newswire Servicers or For Dissemination in the United States / TORONTO , May 29, 2019 /CNW/ - Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: ...

  • Business Wire27 days ago

    Edward Brennan, Jr., M.D., FACS to Lead FSD Pharma BioSciences Division

    FSD Pharma Inc. (HUGE.CN) (FSDDF) (0K9.F) ("FSD" or the "Company"), today announced the appointment of pharmaceutical industry leader, Edward J. Brennan, Jr., M.D., FACS, as President of its biosciences division. Dr. Brennan has more than 25 years’ experience in leadership roles at major pharmaceutical companies and clinical research organizations.

  • CNW Grouplast month

    High Tide Acquires Retail Cannabis Store and E-Commerce Business to Enter Saskatchewan Market

    CALGARY, May 24, 2019 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (CSE:HITI.CN - News) (OTCQB:HITIF - News) (FRA:2LY.F - News), an Alberta-based, retail-focused cannabis corporation enhanced by the manufacturing and wholesale distribution of smoking accessories and cannabis lifestyle products, today announced that it has closed the acquisition of Dreamweavers Cannabis Products Inc. ("Dreamweavers"), a retail cannabis store and e-commerce business currently operating in Swift Current, Saskatchewan as licensed by the Saskatchewan Liquor and Gaming Authority. The consideration paid to close the acquisition of Dreamweavers was $1,550,000 in cash and 3,100,000 of the special warrants previously authorized for issuance on December 14, 2018, consisting in aggregate of 3,100,000 common shares of High Tide and 1,550,000 purchase warrants exercisable at $0.75 per common share of High Tide.

  • CNW Grouplast month

    Canna Cabana Wins Manitoba Draw to Open Cannabis Retail Store and E-Commerce Sales Across the Province

    CALGARY, May 21, 2019 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (CSE:HITI.CN - News) (OTCQB:HITIF - News) (FRA:2LY.F - News), an Alberta-based, retail-focused cannabis corporation enhanced by the manufacturing and wholesale distribution of smoking accessories and cannabis lifestyle products, today announced that Canna Cabana was selected by random algorithmic draw as the Successful Retailer for the community of Niverville during Manitoba's Cannabis Retail Opportunities Draw (the "Draw") held on May 15, 2019.  The opportunity will permit Canna Cabana to be licensed by the Liquor, Gaming and Cannabis Authority of Manitoba to operate a bricks-and-mortar retail store in Niverville as well as e-commerce sales serving the entire province. As the parent company of Canna Cabana, High Tide has confirmed its interest in the Niverville license.

  • FSD Pharma Welcomes All-Star Lineup of Cannabis Researchers to Scientific Advisory Board
    CNW Grouplast month

    FSD Pharma Welcomes All-Star Lineup of Cannabis Researchers to Scientific Advisory Board

    TORONTO, May 20, 2019 /CNW/ - FSD Pharma Inc. (CSE:HUGE.CN - News) (OTCQB:FSDDF - News) (FRA:0K9.F - News) ("FSD" or the "Company"), is pleased to announce that three eminent cannabis researchers have joined the company's Scientific Advisory Board ("SAB"). "We are honored to welcome Daniele Piomelli, Ph.D., Ryan Vandrey, Ph.D. and David Casarett, MD, MA to our Scientific Advisory Board," said Dr. Raza Bokhari, FSD Executive Co-Chairman & Chief Executive Officer.